Watch AMLX. Know when insiders buy.
One email the day a filing lands. Free.
AMLX
Amylyx Pharmaceuticals, Inc.
28.57
−0.46 −1.58%
USD · close Oct 22
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
45
WATCH · insiders 25, shorts 64
Insiders, 90 days
−$3.8M
net selling · 0 buys, 10 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $3.2BP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$152.1MNET CASH —52W 11.38 – 39.66NEXT EARNINGS Nov 5SEC XBRL · TTM TO Invalid Date
One year, everything drawn on
Insider buyInsider sellCongress buy, above the lineCongress sell, below10-K / 10-Q filedHOVER A MARKER FOR THE FILING
THE WORK ORDER · 2026-10-23
Insiders (90d): $3.8M net selling
Shorts (latest report): 12.7M short · −688K last period
Every line of the math45WATCH
Insider activity
ALL 10| Date | Insider | Type | Value |
|---|---|---|---|
| Oct 5 | Director | Sell | $831K |
| Sep 10 | Chief Medical Officer | Sell | $69K |
| Sep 10 | Chief Medical Officer | Sell | $256K |
| Sep 10 | Chief Financial Officer | Sell | $35K |
| Sep 10 | Chief Financial Officer | Sell | $315K |
| Sep 10 | Chief Legal Officer | Sell | $309K |